Vergara-Fernandez O, Navarro-Navarro A, Rangel-Ríos HA, Salgado-Nesme N, Reyes-Monroy JA, Velázquez-Fernández D

Idioma: Ingles.
Referencias bibliográficas: 51
Paginas: 291-300
Archivo PDF: 193.46 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.

2. Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107:djv048.

3. International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide. World Health Organization; 2012. Available from: http:// www.globocan.iarc.fr. [Last accessed on 2018 Jul 14].

4. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-41.

5. Naxerova K, Reiter JG, Brachtel E, et al. Origins of lymphatic and distant metastases in human colorectal cancer. Science. 2017; 357:55-60.

6. Gervasoni JE Jr. Sbayi S, Cady B. Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol. 2007;14:2443-62.

7. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583-96.

8. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. college of American pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124 979-94.

9. McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst. 2006;98:1623-33.

10. Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004;47:1269-84.

11. Cianchi F, Palomba A, Boddi V, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002; 26:384-9.

12. Benson AB 3rd, Schrag D, Somerfield MR, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-19.

13. Tepper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19:157-63.

14. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570-5.

15. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-9.

16. Compton CC. Optimal pathologic staging: defining stage II disease. Clin Cancer Res. 2007;13:6862s-70s.

17. Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum. 2010;53:65-70.

18. Moore J, Hyman N, Callas P, Littenberg B. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival. Surgery. 2010; 147:358-65.

19. Parsons HM, Tuttle TM, Kuntz KM, et al. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306:1089-97.

20. Wong SL, Ji H, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149-54.

21. Vergara-Fernandez O, Swallow CJ, Victor JC, et al. Assessing outcomes following surgery for colorectal cancer using quality of care indicators. Can J Surg. 2010;53:232-40.

22. Tsikitis VL, Larson DL, Wolff BG, et al. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved. J Am Coll Surg. 2009;208:42-7.

23. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: Results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-63.

24. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006;93:439-45.

25. de Campos-Lobato LF, Stocchi L, de Sousa JB, et al. Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: it means more than you think! Ann Surg Oncol. 2013;20:3398-406.

26. Govindarajan A, Gönen M, Weiser MR, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol. 2011;29:4568-73.

27. Morikawa T, Tanaka N, Kuchiba A, et al. Data from US nationwide prospective cohort studies. Predictors of lymph node count in colorectal cancer resections. Arch Surg. 2012;147:715-23.

28. Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol. 2010;17:2847-55.

29. Zhang BB, Chen TT, Wei QZ, Wang GC, Lu M. Risk factors for survival after colorectal cancer resection. Hepatogastroenterology. 2013;60:528-32.

30. Mohan HM, Walsh C, Kennelly R, et al. Lymph node ratio does not provide additional prognostic information compared with the N1/N2 classification in stage III colon cancer. Colorectal Dis. 2017;19:165-71.

31. Leonard D, Remue C, Orabi NA, et al. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre. Colorectal Dis. 2016; 18:O175-84.

32. Hernanz F, Revuelta S, Redondo C, et al. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum. 1994;37:373-6.

33. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106:209-16.

34. Maurel J, Launoy G, Grosclaude P, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer. 1998;82:1482-86.

35. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.

36. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219-25.

37. Mason MC, Chang GJ, Petersen LA, et al. National quality forum colon cancer quality metric performance: how are hospitals measuring up? Ann Surg. 2017;266:1013-20.

38. Brown HG, Luckasevic TM, Medich DS, Celebrezze JP, Jones SM. Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol. 2004;17:402-6.

39. Herrera-Ornelas L, Justiniano J, Castillo N, et al. Metastases in small lymph nodes from colon cancer. Arch Surg. 1987; 122:1253-6.

40. Sluijter CE, van Lonkhuijzen LR, van Slooten HJ, Nagtegaal ID, Overbeek LI. The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review. Virchows Arch. 2016;468:639-49.

41. Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G. Clinical outcomes of surgical therapy (COST) study group Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002;287:321-8.

42. Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the medical research council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100:75-82.

43. Colon Cancer Laparoscopic or Open Resection Study Group, Buunen M, Veldkamp R, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009;10:44 52.

44. Bagshaw PF, Allardyce RA, Frampton CM, et al. Australasian laparoscopic colon cancer study group. Long-term outcomes of the Australasian randomized clinical trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian laparoscopic colon cancer study trial. Ann Surg. 2012;256:915-9.

45. Feinberg AE, Chesney TR, Acuna SA, Sammour T, Quereshy FA. Oncologic outcomes following laparoscopic versus open resection of pT4 colon cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2017;60:116-25.

46. Abdel-Misih SR, Wei L, Benson AB 3rd, et al. Neoadjuvant therapy for rectal cancer affects lymph node yield and status without clear implications on outcome: the case for eliminating a metric and utilizing preoperative staging to guide therapy. J Natl Compr Canc Netw. 2016;14:1528-34.

47. Al-Sukhni E, Attwood K, Gabriel EM, et al. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study. Int J Surg. 2017;37:42-9.

48. Yun JA, Kim HC, Kim SH, et al. Prognostic significance of perineural invasion in stage IIA colon cancer. ANZ J Surg. 2016; 86:1007-13.

49. Mirkin KA, Hollenbeak CS, Mohamed A, et al. Impact of perineural invasion on survival in node negative colon cancer. Cancer Biol Ther. 2017;18:740-5.

50. Chin CC, Wang JY, Yeh CY, et al. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis. 2009;24:1297-302.

51. Lykke J, Jess P, Roikjaer O, Danish Colorectal Cancer Group. The prognostic value of lymph node ratio in a national cohort of rectal cancer patients. Eur J Surg Oncol. 2016;42:504-12.